Your session is about to expire
← Back to Search
Antioxidant
MitoQ for Chronic Kidney Disease
Phase 4
Waitlist Available
Led By David G Edwards, PhD
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Stage 3 - 5 Chronic Kidney Disease
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 4 weeks
Awards & highlights
Summary
The purpose of this study is to examine the effect of mitochondria derived oxidative stress on vascular function in patients with moderate to severe Chronic Kidney Disease.
Eligible Conditions
- Chronic Kidney Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 4 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Microvascular Function, assessed by laser Doppler flowmetry coupled with microdialysis
Secondary study objectives
Conduit artery endothelial dependent dilation, assessed by duplex ultrasound
Mitochondria derived superoxide, assessed by electron paramagnetic resonance spectroscopy
Other study objectives
Ambulatory Blood Pressure
Arterial Stiffness, assessed by central blood pressure, augmentation index and carotid artery to femoral artery pulse wave velocity
Endothelial cell NADPH oxidase expression
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: MitoQExperimental Treatment1 Intervention
4 week 20mg oral daily dose of MitoQ
Group II: PlaceboPlacebo Group1 Intervention
4 week 20mg oral daily placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MitoQ
2006
Completed Phase 2
~230
Find a Location
Who is running the clinical trial?
University of DelawareLead Sponsor
161 Previous Clinical Trials
25,672 Total Patients Enrolled
David G Edwards, PhDPrincipal InvestigatorUniversity of Delaware
3 Previous Clinical Trials
195 Total Patients Enrolled
Danielle L Kirkman, PhDPrincipal InvestigatorUniversity of Delaware
1 Previous Clinical Trials
25 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger